proteomic changes upon treatment with semaglutide in individuals with obesity results week by week: timeline from first dose to full results Super interesting Novo Nordisk Nature

Take RYBELSUS on an empty stomach in the morning with water (up to 4 ounces of water)

In another study, people who paired semaglutide with a structured lifestyle program lost slightly more during treatment and regained less afterward

Older Adults Seniors need special attention with GLP-1 medicines

Risk factors that may prompt additional consideration include: Active gastrointestinal symptoms (nausea, vomiting, abdominal pain) Recent dose increases or being in the dose-escalation phase Higher doses of semaglutide Known gastroparesis or other conditions affecting gastric emptying Obesity with GERD or hiatal hernia Based on the 2024 multi-society guidance, most patients can continue GLP-1 receptor agonists before elective procedures with appropriate risk assessment and mitigation strategies, rather than automatic postponement